US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 28, 2014 (12 years ago)

Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component.

What was recalled

Oxycodone and Acetaminophen Tablets USP 10 mg/325 mg 100 count bottles Rx Only. Manufactured by Norwich Pharmaceuticals Inc., Norwich, NY 13185 USA; Distributed by Alvogen Inc, Pine Brook NJ 07058 USA.

Recalling firm
Alvogen, Inc
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1607-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Acetaminophen recalls

See all
Class II · Moderate risk Ongoing

Oxycodone and Acetaminophen CII Tablets USP

Reason Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC NDC 0406-0522-01 D-0255-2026
Class II · Moderate risk Ongoing

Oxycodone and Acetaminophen CII Tablets USP

Reason Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.

SpecGx, LLC NDC 0406-0523-01 D-0254-2026
Class II · Moderate risk Ongoing

Tylenol

Reason Defective Container

Kenvue Brands LLC D-0121-2026
Class II · Moderate risk Ongoing

Acetaminophen 500mg Caffeine 65mg caplets

Reason Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.

Aero Healthcare NDC 55305-135-01 D-0155-2026